Solriamfetol for fatigue in multiple sclerosis
Treatments studied
Part of Brain & nervous system, Immune system & allergy, Mental health clinical trials.
This study tests whether solriamfetol, a medication that promotes wakefulness, can reduce fatigue in people with multiple sclerosis. If you struggle with tiredness and sleepiness, this trial may help you understand how this drug works for MS-related fatigue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old
- Have a diagnosis of multiple sclerosis (MS) and fatigue as a main symptom
- Feel very sleepy during the day (score 10 or more on a sleepiness scale)
- Be able to walk at least 20 feet with help from a cane, walker, or other device
- Have access to internet and email, and own a smartphone (Android or iPhone)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an online self-management program to help reduce fatigue in people with MS. You'll use a website or app over 24 weeks, and researchers will check how well it works.
This trial tests if a smartphone app and activity tracker can help reduce fatigue in people with Multiple Sclerosis. You will use the app and wear a small device to track your activity, while receiving support to manage your energy levels. The goal is to see if this helps more than standard care alone.
This study uses a safe, non-invasive brain stimulation technique to see if it can reduce fatigue in people with relapsing-remitting MS. It compares people with and without fatigue to understand how the brain is affected.
This trial tests whether a virtual reality headset that uses gamma sensory stimulation can help reduce fatigue in people with multiple sclerosis. You would use the headset at home and report your fatigue levels.
This study looks at how multiple sclerosis (MS) affects your thinking, sleep, and tiredness. It compares people with MS who have at least mild fatigue to people without MS who also have sleep problems, to understand these issues better.
This study looks at how taking teriflunomide (an oral medication) affects tiredness and daily activities in people with relapsing multiple sclerosis. It will follow you for a year, checking your energy levels and physical function through simple tests and questionnaires.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.